PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, UK, and is a spinoff of the University of Cambridge.
Discover how we are reimagining small molecule therapeutics through AI at pharmenabletx.com and connect with us on LinkedIn.
Company Details
- Employees
- 16
- Address
- Compass House, Vision Park, Histon, Cambridge,cambridgeshire Cb24 9ad,united Kingdom
- in****@****ble.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pharmenabletx.com
- HQ
- Cambridge, Cambridgeshire
Pharmenable Therapeutics Questions
Pharmenable Therapeutics's website is http://www.pharmenabletx.com
Pharmenable Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/pharmenable
Pharmenable Therapeutics has
16 employees.
View email and phone details for 16
employees at Pharmenable Therapeutics.
Pharmenable Therapeutics's industry is
Biotechnology Research
Pharmenable Therapeutics's top competitors are
Spirea,
Concr,
Storm Therapeutics Limited,
Sixfold Bioscience,
52north - Creators Of Neutrocheck®,
Verinnogen,
Phoremost Ltd,
Biomodal,
Astex Pharmaceuticals,
T-Therapeutics Ltd.
Pharmenable Therapeutics's support email address is info@pharmenable.com
Pharmenable Therapeutics's categories are Biotechnology Research
